Homebiogas (HMGS) AI Stock Analysis

2 Followers

Homebiogas

(TASE:HMGS)

Select Model

Rating:44Neutral

Price Target:ILA 64.00▼(-3.76% Downside)

Action:reiterated

Date:11/12/26

The score is primarily constrained by persistent unprofitability, negative cash generation, and weak technical momentum. Improving revenue, margins, deleveraging, and lower cash burn provide some support, but the negative P/E and ongoing equity erosion indicate substantial risk.

Positive Factors

Decentralized cleantech platformHomeBiogas addresses two persistent needs through one product: decentralized organic-waste treatment and renewable cooking energy. This integrated proposition can remain relevant across household, farm, and institutional customers as demand grows for low-carbon and off-grid solutions.

Negative Factors

Large ongoing lossesThe company remains far from breakeven, with operating costs substantially exceeding its current revenue base. Persistent net losses weaken internal funding capacity and make future growth more dependent on successfully expanding sales, improving margins, and controlling operating expenses.

Homebiogas (HMGS) vs. iShares MSCI Israel ETF (EIS)

Market Cap: ILS 18.84M
Dividend Yield: ―
Average Volume (3M): 140.56K
Price to Earnings (P/E): -1.2
Beta (1Y): 0.12
Revenue Growth: -10.23%
EPS Growth: 35.34%
Country: Israel
Employees: 71
Sector: General
Sector Strength: 55
Industry: Renewable Utilities

Homebiogas Business Overview & Revenue Model

Company Description

HomeBiogas LTD develops, produces, and markets innovative biogas systems that convert organic waste into clean energy. These solutions serve a broad international clientele, including private homes, agricultural businesses, commercial entities, and l...

How the Company Makes Money

HomeBiogas primarily makes money by selling physical anaerobic digestion systems (and related equipment) that customers install and use to convert organic waste into usable biogas. Revenue is generated from (1) product sales of its biogas digester un...

Homebiogas Financial Statement Overview

Summary

Revenue and gross margins improved, while leverage and cash burn declined. However, persistent net losses, negative operating cash flow, and severe equity erosion keep financial performance weak.

Income Statement

35Negative

Balance Sheet

65Positive

Cash Flow

45Neutral

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	3.10M	3.13M	2.63M	4.83M	4.70M	2.48M
Gross Profit	1.25M	899.53K	384.00K	1.55M	1.34M	234.00K
EBITDA	-4.44M	-3.76M	-8.23M	-9.91M	-14.00M	-7.64M
Net Income	-5.27M	-4.14M	-9.42M	-11.34M	-15.16M	-8.31M
Balance Sheet
Total Assets	6.03M	5.23M	8.21M	19.43M	19.62M	33.58M
Cash, Cash Equivalents and Short-Term Investments	2.34M	1.95M	2.84M	9.14M	11.20M	26.05M
Total Debt	343.00K	391.08K	470.00K	1.95M	1.64M	1.99M
Total Liabilities	3.20M	2.16M	3.23M	5.39M	5.23M	5.49M
Stockholders Equity	2.81M	2.79M	4.93M	14.04M	14.39M	28.09M
Cash Flow
Free Cash Flow	-3.06M	-2.44M	-5.54M	-11.13M	-12.77M	-10.72M
Operating Cash Flow	-3.00M	-2.43M	-4.51M	-10.58M	-11.57M	-8.33M
Investing Cash Flow	-10.57K	169.95K	-847.00K	-571.00K	-1.13M	-2.49M
Financing Cash Flow	2.79M	1.02M	-639.00K	9.28M	-419.00K	28.77M

Homebiogas Technical Analysis

Technical Analysis SentimentNegative

Last Price66.50

Price Trends

50DMA79.67Negative

100DMA81.03Negative

200DMA77.24Negative

Market Momentum

MACD-4.79Positive

RSI40.41Neutral

STOCH28.14Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HMGS, the sentiment is Negative. The current price of 66.50 is below the 20-day moving average (MA) of 73.09, below the 50-day MA of 79.67, and below the 200-day MA of 77.24, indicating a bearish trend. The MACD of -4.79 indicates Positive momentum. The RSI at 40.41 is Neutral, neither overbought nor oversold. The STOCH value of 28.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HMGS.

Homebiogas Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IL:HMGS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IL:ECNR	55Neutral	ILS 4.59B	-20.95	―	―	2.40%	-570.07%
IL:SBEN	47Neutral	ILS 3.89B	-13.63	―	―	64.06%	-1059.35%
IL:ZPRS	45Neutral	ILS 1.59B	-28.99	―	―	―	―
IL:MSKE	45Neutral	ILS 6.70B	-52.98	―	―	―	―
IL:HMGS	44Neutral	ILS 29.19M	-1.20	―	―	-10.23%	35.34%

* General Sector Average

Performance Comparison

IL:HMGS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IL:HMGS	HOMEBIOGAS LTD	66.50	-73.30	-52.43%
IL:MSKE	Meshek Energy Renewable Energies Ltd.	903.50	253.60	39.02%
IL:PRIM	Prime Energy P.E. LTD	3337.00	1959.00	142.16%
IL:ECNR	Econergy renewable energy Ltd	5857.00	1545.00	35.83%
IL:SBEN	SHIKUN & BINUI ENERGY LTD	390.00	110.40	39.48%
IL:ZPRS	Zephyrus Wing Energies Ltd.	2216.00	276.00	14.23%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 12, 2026

Homebiogas AI Stock Analysis